An international panel assembled by the International AIDS Society has agreed that tests for HIV drug resistance need to be used with caution until more is known about the clinical implications of particular drug resistance mutations. In a review published in the Journal of the American Medical Association (http://www.ama-assn.org/sci-pubs/journals/most/recent/issues/jama/st80001a.htm) the authors conclude that more work is needed to standardise the tests, and that drug resistance tests should only be used when other causes of treatment failure have been ruled out.
An international panel assembled by the International AIDS Society has agreed that tests for HIV drug resistance need to be used with caution until more is known about the clinical implications of particular drug resistance mutations. In a review published in the Journal of the American Medical Association (http://www.ama-assn.org/sci-pubs/journals/most/recent/issues/jama/st80001a.htm) the authors conclude that more work is needed to standardise the tests, and that drug resistance tests should only be used when other causes of treatment failure have been ruled out.
--------